Indications and uses
for relief of occasional sleeplessness when associated with minor aches and pains helps you fall asleep and stay asleep
for relief of occasional sleeplessness when associated with minor aches and pains helps you fall asleep and stay asleep
do not take more than directed drink a full glass of water with each dose adults and children 12 years and over: take 2 caplets at bedtime do not take more than 2 caplets in 24 hours if taken with food, this product may take longer to work
read all warnings and directions before use. Keep outer carton. each caplet contains: sodium 20 mg store at 20-25°C (68-77°F) avoid high humidity and excessive heat above 40°C (104°F)
Drug Facts
Allergy alert
Naproxen sodium may cause a severe allergic reaction, especially in people allergic to aspirin. Symptoms may include:
If an allergic reaction occurs, stop use and seek medical help right away.
Stomach bleeding warning
This product contains an NSAID, which may cause severe stomach bleeding. The chance is higher if you:
Heart attack and stroke warning
NSAIDs, except aspirin, increase the risk of heart attack, heart failure, and stroke. These can be fatal. The risk is higher if you use more than directed or for longer than directed.
If pregnant or breast-feeding, ask a health professional before use. It is especially important not to use naproxen sodium 20 weeks or later in pregnancy unless definitely directed to do so by a doctor because it may cause problems in the unborn child or complications during delivery.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
carnauba wax, FD&C blue #2 aluminum lake, hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, povidone, purified water, talc, titanium dioxide
1-800-395-0689 (Mon – Fri 9AM – 5PM EST)
Aleve® PM
naproxen sodium, 220 mg (NSAID)/
diphenhydramine HCl, 25 mg
Pain reliever/nighttime sleep-aid
SLEEP AID PLUS
12 HOUR PAIN RELIEVING
STRENGTH OF ALEVE
ACTUAL SIZE
20 CAPLETS
*CAPSULE-SHAPED TABLETS
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 1550963 | Aleve PM 25 MG / 220 MG Oral Tablet | PSN | 16 |
| 1550957 | diphenhydrAMINE HCl 25 MG / naproxen sodium 220 MG Oral Tablet | PSN | 16 |
| 1550963 | diphenhydramine hydrochloride 25 MG / naproxen sodium 220 MG Oral Tablet [Aleve PM] | SBD | 16 |
| 1550957 | diphenhydramine hydrochloride 25 MG / naproxen sodium 220 MG Oral Tablet | SCD | 16 |
| 1550963 | Aleve PM (diphenhydramine hydrochloride 25 MG / naproxen sodium 220 MG) Oral Tablet | SY | 16 |
| Class | Version | Type | Effective |
|---|---|---|---|
| DIPHENHYDRAMINE Pharmacologic Class Indexing | 3 | Indexing - Pharmacologic Class | 20180813 |
| NAPROXEN Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20191108 |
| Resource | Code type | Value | Equivalent identifiers | Source image |
|---|---|---|---|---|
| Barcode | EAN-13 | 0025866591882 | GTIN-13: 0025866591882 EAN-13: 0025866591882 GTIN-12: 025866591882 UPC-A: 025866591882 GTIN storage (14 digits): 00025866591882 | Aleve PM 20 count Carton.jpg |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| fef6ad89-235f-4274-ba49-a8e53642473e | Product name | 2 | 20250225 |
| 0e2e0f88-b076-afe1-4bdd-32bca4375bec | Product name | 3 | 20250127 |
| 87fed3e6-8fba-48ef-96b0-3a7fb54b96ff | Product name | 3 | 20230306 |
| b5fdaaec-7251-4da6-9cb2-4e9e76939ec8 | Product name | 1 | 20200623 |
| e76dbbc1-775d-722c-08ff-ed45e8a80def | Product name | 3 | 20181002 |
| 3e48c9c4-918d-5d23-2f0b-d2398b06be54 | Product name | 1 | 20140508 |
| 6f4f4521-fd56-1ae6-888b-3b021bd75c7c | Product name | 1 | 20140508 |
| 865c72dd-0d94-daac-f728-ddd4ded2a79e | Product name | 1 | 20140508 |
| ce67e27d-1d21-5465-4409-b0662dd99d4d | Product name | 1 | 20140508 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0280-1200-01 | Aleve PM | 120 in 1 BOTTLE | TABLET, FILM COATED | 120 | 16 | |
| 0280-1200-01 | Aleve PM | 1 in 1 CARTON | TABLET, FILM COATED | 1 | 16 | |
| 0280-1200-02 | Aleve PM | 2 in 1 POUCH | TABLET, FILM COATED | 2 | 16 | |
| 0280-1200-03 | Aleve PM | 160 in 1 BOTTLE | TABLET, FILM COATED | 160 | 16 | |
| 0280-1200-04 | Aleve PM | 1 in 1 CARTON | TABLET, FILM COATED | 1 | 16 | |
| 0280-1200-04 | Aleve PM | 40 in 1 BOTTLE | TABLET, FILM COATED | 40 | 16 | |
| 0280-1200-05 | Aleve PM | 80 in 1 BOTTLE | TABLET, FILM COATED | 80 | 16 | |
| 0280-1200-08 | Aleve PM | 250 in 1 BOTTLE | TABLET, FILM COATED | 250 | 16 | |
| 0280-1200-08 | Aleve PM | 1 in 1 CARTON | TABLET, FILM COATED | 1 | 16 | |
| 0280-1200-20 | Aleve PM | 1 in 1 CARTON | TABLET, FILM COATED | 1 | 16 | |
| 0280-1200-20 | Aleve PM | 20 in 1 BOTTLE | TABLET, FILM COATED | 20 | 16 | |
| 0280-1200-40 | Aleve PM | 1 in 1 CARTON | TABLET, FILM COATED | 1 | 16 | |
| 0280-1200-40 | Aleve PM | 40 in 1 BOTTLE | TABLET, FILM COATED | 40 | 16 | |
| 0280-1200-80 | Aleve PM | 80 in 1 BOTTLE | TABLET, FILM COATED | 80 | 16 | |
| 0280-1200-80 | Aleve PM | 1 in 1 CARTON | TABLET, FILM COATED | 1 | 16 |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0280-1200-08 | EA - Each | 0280-1200 | 7162e0ff-5f6c-4faf-9e4b-d504cff9c3bb | 1 | 2025-05-14 |
| 0280-1200-20 | EA - Each | 0280-1200 | 212e63c7-774e-4441-ab13-a909fe2f7d9a | 1 | 2025-05-14 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| DIPHENHYDRAMINE HYDROCHLORIDE | ACTIVE INGREDIENT | TC2D6JAD40 | 1 | |
| NAPROXEN SODIUM | ACTIVE INGREDIENT | 9TN87S3A3C | 1 | |
| DIPHENHYDRAMINE | ACTIVE MOIETY | 8GTS82S83M | 1 | |
| NAPROXEN | ACTIVE MOIETY | 57Y76R9ATQ | 1 | |
| ALUMINUM OXIDE | INACTIVE INGREDIENT | LMI26O6933 | 1 | |
| CARNAUBA WAX | INACTIVE INGREDIENT | R12CBM0EIZ | 1 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | 1 | |
| FD&C BLUE NO. 2 | INACTIVE INGREDIENT | L06K8R7DQK | 1 | |
| HYPROMELLOSES | INACTIVE INGREDIENT | 3NXW29V3WO | 1 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | 1 | |
| POLYETHYLENE GLYCOLS | INACTIVE INGREDIENT | 3WJQ0SDW1A | 1 | |
| POVIDONES | INACTIVE INGREDIENT | FZ989GH94E | 1 | |
| TALC | INACTIVE INGREDIENT | 7SEV7J4R1U | 1 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 0280-1200 | 0280-1200-02, 0280-1200-20, 0280-1200-40, 0280-1200-80, 0280-1200-01, 0280-1200-08, 0280-1200-03, 0280-1200-04, 0280-1200-05 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| FD&C BLUE NO. 2 | L06K8R7DQK | IACT |
| ALUMINUM OXIDE | LMI26O6933 | IACT |
| HYPROMELLOSES | 3NXW29V3WO | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| CELLULOSE, MICROCRYSTALLINE | OP1R32D61U | IACT |
| POLYETHYLENE GLYCOL, UNSPECIFIED | 3WJQ0SDW1A | IACT |
| CARNAUBA WAX | R12CBM0EIZ | IACT |
| POVIDONE | FZ989GH94E | IACT |
| WATER | 059QF0KO0R | IACT |
| TALC | 7SEV7J4R1U | IACT |
| TITANIUM DIOXIDE | 15FIX9V2JP | IACT |
| DIPHENHYDRAMINE HYDROCHLORIDE | TC2D6JAD40 | ACTIB |
| NAPROXEN SODIUM | 9TN87S3A3C | ACTIB |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, FILM COATED / ORAL | 96 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, FILM COATED / ORAL | 96 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, FILM COATED / ORAL | 96 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, FILM COATED / ORAL | 36 mg | ||
| CARNAUBA WAX | CARNAUBA WAX | R12CBM0EIZ | TABLET, FILM COATED / ORAL | 1 mg | ||
| ALUMINUM OXIDE | ALUMINUM OXIDE | LMI26O6933 | TABLET / ORAL | NA | ||
| FD&C BLUE NO. 2 | FD&C BLUE NO. 2 | L06K8R7DQK | TABLET, FILM COATED / ORAL | 2 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, FILM COATED / ORAL | 96 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, FILM COATED / ORAL | 36 mg | ||
| ALUMINUM OXIDE | ALUMINUM OXIDE | LMI26O6933 | TABLET / ORAL | NA | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, FILM COATED / ORAL | 36 mg | ||
| FD&C BLUE NO. 2 | FD&C BLUE NO. 2 | L06K8R7DQK | TABLET, FILM COATED / ORAL | 2 mg | ||
| ALUMINUM OXIDE | ALUMINUM OXIDE | LMI26O6933 | TABLET / ORAL | NA | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, FILM COATED / ORAL | 96 mg | ||
| FD&C BLUE NO. 2 | FD&C BLUE NO. 2 | L06K8R7DQK | TABLET, FILM COATED / ORAL | 2 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, FILM COATED / ORAL | 91 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET, FILM COATED / ORAL | 582 mg | ||
| FD&C BLUE NO. 2 | FD&C BLUE NO. 2 | L06K8R7DQK | TABLET, FILM COATED / ORAL | 2 mg | ||
| FD&C BLUE NO. 2 | FD&C BLUE NO. 2 | L06K8R7DQK | TABLET, FILM COATED / ORAL | 2 mg | ||
| POVIDONES | POVIDONE | FZ989GH94E | TABLET, FILM COATED / ORAL | 240 mg | ||
| CARNAUBA WAX | CARNAUBA WAX | R12CBM0EIZ | TABLET, FILM COATED / ORAL | 1 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET, FILM COATED / ORAL | 582 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET, FILM COATED / ORAL | 582 mg | ||
| ALUMINUM OXIDE | ALUMINUM OXIDE | LMI26O6933 | TABLET / ORAL | NA | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, FILM COATED / ORAL | 992 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, FILM COATED / ORAL | 91 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, FILM COATED / ORAL | 36 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, FILM COATED / ORAL | 91 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, FILM COATED / ORAL | 91 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, FILM COATED / ORAL | 992 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, FILM COATED / ORAL | 992 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, FILM COATED / ORAL | 91 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET, FILM COATED / ORAL | 582 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, FILM COATED / ORAL | 992 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, FILM COATED / ORAL | 96 mg | ||
| POVIDONES | POVIDONE | FZ989GH94E | TABLET, FILM COATED / ORAL | 240 mg | ||
| ALUMINUM OXIDE | ALUMINUM OXIDE | LMI26O6933 | TABLET / ORAL | NA | ||
| ALUMINUM OXIDE | ALUMINUM OXIDE | LMI26O6933 | TABLET / ORAL | NA | ||
| ALUMINUM OXIDE | ALUMINUM OXIDE | LMI26O6933 | TABLET / ORAL | NA | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, FILM COATED / ORAL | 91 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET, FILM COATED / ORAL | 582 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, FILM COATED / ORAL | 992 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, FILM COATED / ORAL | 36 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET, FILM COATED / ORAL | 582 mg | ||
| ALUMINUM OXIDE | ALUMINUM OXIDE | LMI26O6933 | TABLET / ORAL | NA | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, FILM COATED / ORAL | 96 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, FILM COATED / ORAL | 992 mg | ||
| FD&C BLUE NO. 2 | FD&C BLUE NO. 2 | L06K8R7DQK | TABLET, FILM COATED / ORAL | 2 mg | ||
| FD&C BLUE NO. 2 | FD&C BLUE NO. 2 | L06K8R7DQK | TABLET, FILM COATED / ORAL | 2 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET, FILM COATED / ORAL | 582 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, FILM COATED / ORAL | 992 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET, FILM COATED / ORAL | 582 mg | ||
| ALUMINUM OXIDE | ALUMINUM OXIDE | LMI26O6933 | TABLET / ORAL | NA | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, FILM COATED / ORAL | 36 mg | ||
| CARNAUBA WAX | CARNAUBA WAX | R12CBM0EIZ | TABLET, FILM COATED / ORAL | 1 mg | ||
| POVIDONES | POVIDONE | FZ989GH94E | TABLET, FILM COATED / ORAL | 240 mg | ||
| CARNAUBA WAX | CARNAUBA WAX | R12CBM0EIZ | TABLET, FILM COATED / ORAL | 1 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, FILM COATED / ORAL | 96 mg | ||
| ALUMINUM OXIDE | ALUMINUM OXIDE | LMI26O6933 | TABLET / ORAL | NA | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, FILM COATED / ORAL | 91 mg |
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N205352-001 | ALEVE PM | DIPHENHYDRAMINE HYDROCHLORIDE; NAPROXEN SODIUM | 25MG;220MG | TABLET / ORAL | RLD, RS | 2014-01-17 |
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | N205352-001 | ALEVE PM | 25MG;220MG | TABLET / ORAL | RLD, RS | 2014-01-17 | d4dbc9d85df4… | |
| 2026-10-15 13:18:30 | 2026-09 | N205352-001 | ALEVE PM | 25MG;220MG | TABLET / ORAL | RLD, RS | 2014-01-17 | c2088c7a36db… | |
| 2026-09-14 22:38:34 | 2026-08 | N205352-001 | ALEVE PM | 25MG;220MG | TABLET / ORAL | RLD, RS | 2014-01-17 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N205352-001 | ALEVE PM | 25MG;220MG | TABLET / ORAL | RLD, RS | 2014-01-17 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N205352-001 | ALEVE PM | 25MG;220MG | TABLET / ORAL | RLD, RS | 2014-01-17 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N205352-001 | ALEVE PM | 25MG;220MG | TABLET / ORAL | RLD, RS | 2014-01-17 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N205352-001 | ALEVE PM | 25MG;220MG | TABLET / ORAL | RLD, RS | 2014-01-17 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N205352-001 | ALEVE PM | 25MG;220MG | TABLET / ORAL | RLD, RS | 2014-01-17 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N205352-001 | ALEVE PM | 25MG;220MG | TABLET / ORAL | RLD, RS | 2014-01-17 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N205352-001 | ALEVE PM | 25MG;220MG | TABLET / ORAL | RLD, RS | 2014-01-17 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N205352-001 | ALEVE PM | 25MG;220MG | TABLET / ORAL | RLD, RS | 2014-01-17 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N205352-001 | ALEVE PM | 25MG;220MG | TABLET / ORAL | RLD, RS | 2014-01-17 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N205352-001 | ALEVE PM | 25MG;220MG | TABLET / ORAL | RLD, RS | 2014-01-17 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N205352-001 | ALEVE PM | 25MG;220MG | TABLET / ORAL | RLD, RS | 2014-01-17 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N205352-001 | ALEVE PM | 25MG;220MG | TABLET / ORAL | RLD, RS | 2014-01-17 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N205352-001 | ALEVE PM | 25MG;220MG | TABLET / ORAL | RLD, RS | 2014-01-17 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N205352-001 | ALEVE PM | 25MG;220MG | TABLET / ORAL | RLD, RS | 2014-01-17 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N205352-001 | ALEVE PM | 25MG;220MG | TABLET / ORAL | RLD, RS | 2014-01-17 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N205352-001 | ALEVE PM | 25MG;220MG | TABLET / ORAL | RLD, RS | 2014-01-17 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N205352-001 | ALEVE PM | 25MG;220MG | TABLET / ORAL | RLD, RS | 2014-01-17 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N205352-001 | ALEVE PM | 25MG;220MG | TABLET / ORAL | RLD, RS | 2014-01-17 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | N205352-001 | ALEVE PM | 25MG;220MG | TABLET / ORAL | RLD, RS | 2014-01-17 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | N205352-001 | ALEVE PM | 25MG;220MG | TABLET / ORAL | RLD, RS | 2014-01-17 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | N205352-001 | ALEVE PM | 25MG;220MG | TABLET / ORAL | RLD, RS | 2014-01-17 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N205352-001 | ALEVE PM | 25MG;220MG | TABLET / ORAL | RLD, RS | 2014-01-17 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | N205352-001 | ALEVE PM | 25MG;220MG | TABLET / ORAL | RLD, RS | 2014-01-17 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | N205352-001 | ALEVE PM | 25MG;220MG | TABLET / ORAL | RLD, RS | 2014-01-17 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | N205352-001 | ALEVE PM | 25MG;220MG | TABLET / ORAL | RLD, RS | 2014-01-17 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | N205352-001 | ALEVE PM | 25MG;220MG | TABLET / ORAL | RLD, RS | 2014-01-17 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | N205352-001 | ALEVE PM | 25MG;220MG | TABLET / ORAL | RLD, RS | 2014-01-17 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | N205352-001 | ALEVE PM | 25MG;220MG | TABLET / ORAL | RLD, RS | 2014-01-17 | ea99ee380514… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N205352-001 | ALEVE PM | 25MG;220MG | TABLET / ORAL | RLD, RS | 2014-01-17 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | N205352-001 | ALEVE PM | 25MG;220MG | TABLET / ORAL | RLD, RS | 2014-01-17 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | N205352-001 | ALEVE PM | 25MG;220MG | TABLET / ORAL | RLD, RS | 2014-01-17 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N205352-001 | ALEVE PM | 25MG;220MG | TABLET / ORAL | RLD, RS | 2014-01-17 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N205352-001 | ALEVE PM | 25MG;220MG | TABLET / ORAL | RLD, RS | 2014-01-17 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N205352-001 | ALEVE PM | 25MG;220MG | TABLET / ORAL | RLD, RS | 2014-01-17 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N205352-001 | ALEVE PM | 25MG;220MG | TABLET / ORAL | RLD, RS | 2014-01-17 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | N205352-001 | ALEVE PM | 25MG;220MG | TABLET / ORAL | RLD, RS | 2014-01-17 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | N205352-001 | ALEVE PM | 25MG;220MG | TABLET / ORAL | RLD, RS | 2014-01-17 | 3bdfa0b2c4d7… |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Aleve PM | DIPHENHYDRAMINE HYDROCHLORIDE AND NAPROXEN SODIUM | Bayer HealthCare LLC. | 82891458-ab0d-459a-8602-dcebd22c3010 | 2025-12-04 | Warnings | 0280-1200-02 0280-1200-04 0280-1200-05 0280-1200-03 0280-1200-80 0280-1200-08 0280-1200-20 0280-1200-01 0280-1200-40 0280-1200 00280120001 00280120005 00280120080 00280120004 00280120002 00280120008 00280120020 00280120003 00280120040 45265ccc-d985-a6ad-e063-6394a90a75b7 82891458-ab0d-459a-8602-dcebd22c3010 |
Adverse event summaries are temporarily unavailable. Other product information remains available.